Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
- First Posted Date
- 2016-04-18
- Last Posted Date
- 2023-08-21
- Target Recruit Count
- 97
- Registration Number
- NCT02741323
- Locations
- 🇺🇸
UCLA HIVTR-CCR5 Non-Network CRS, Los Angeles, California, United States
🇺🇸UAB HIVTR-CCR5 Non-Network CRS, Birmingham, Alabama, United States
🇺🇸UCSF HIVTR-CCR5 Non-network CRS, San Francisco, California, United States
Auranofin for Giardia Protozoa
- First Posted Date
- 2016-04-13
- Last Posted Date
- 2023-01-26
- Target Recruit Count
- 93
- Registration Number
- NCT02736968
- Locations
- 🇧🇩
International Center for Diarrheal Disease Research Bangladesh - Parasitology, Dhaka, Bangladesh
🇧🇩Rajshahi Medical College Hospital, Rajshahi 6000, Bangladesh
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
Type 1 Diabetes Extension Study
- Conditions
- Type 1 Diabetes MellitusT1DT1DM
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 111
- Registration Number
- NCT02734277
- Locations
- 🇺🇸
Benaroya Research Institute, Seattle, Washington, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Indiana University Riley Hospital for Children, Indianapolis, Indiana, United States
Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men
- Conditions
- HIV Infections
- Interventions
- Drug: Cabotegravir Oral TabletDrug: TDF/FTC tabletsDrug: Placebo for cabotegravir oral tabletDrug: Placebo for CAB LADrug: Placebo for TDF/FTC tabletsDrug: CAB LA
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2024-11-25
- Target Recruit Count
- 4570
- Registration Number
- NCT02720094
- Locations
- 🇵🇪
San Miguel CRS, Lima, Peru
🇺🇸Penn Prevention CRS, Philadelphia, Pennsylvania, United States
🇺🇸Fenway Health (FH) CRS, Boston, Massachusetts, United States
Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men
- Conditions
- HIV Infections
- Interventions
- Biological: VRC01Biological: Placebo for VRC01
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2022-02-23
- Target Recruit Count
- 2699
- Registration Number
- NCT02716675
- Locations
- 🇺🇸
Columbia P&S CRS, New York, New York, United States
🇺🇸University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States
🇺🇸Bronx Prevention Research Center CRS, Bronx, New York, United States
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
- Conditions
- Renal TransplantAdult Living Donor Kidney Transplant RecipientsKidney TransplantLiving Kidney Donor
- Interventions
- Biological: Polyclonal Regulatory T CellsDrug: TacrolimusDrug: Mycophenolate mofetilDrug: EverolimusDrug: Mycophenolic acidDrug: AcetaminophenDrug: DiphenhydramineProcedure: Biopsy, KidneyProcedure: Blood DrawProcedure: LeukapheresisProcedure: IS regimen conversion
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2024-10-07
- Target Recruit Count
- 32
- Registration Number
- NCT02711826
- Locations
- 🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸University of Colorado Health Transplant Center - Anschutz, Aurora, Colorado, United States
Cockroach Nasal Allergen Challenge Pilot
- Conditions
- Cockroach HypersensitivityAsthma
- Interventions
- Biological: Glycerinated German Cockroach Allergenic Extract
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2018-09-25
- Target Recruit Count
- 35
- Registration Number
- NCT02710136
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸UT Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
- Conditions
- Bacterial Vaginosis
- Interventions
- Other: PlaceboDrug: 5% Monolaurin Vaginal Gel
- First Posted Date
- 2016-03-15
- Last Posted Date
- 2018-12-28
- Target Recruit Count
- 109
- Registration Number
- NCT02709005
- Locations
- 🇺🇸
University of Iowa - Vaccine Research and Education Unit, Iowa City, Iowa, United States
🇺🇸Duke Human Vaccine Institute - Duke Clinical Vaccine Unit, Durham, North Carolina, United States
🇺🇸Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
Cefixime / Azithromycin pK Study
- First Posted Date
- 2016-03-15
- Last Posted Date
- 2017-09-15
- Target Recruit Count
- 10
- Registration Number
- NCT02708992
- Locations
- 🇺🇸
Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham, North Carolina, United States